Back to results
US 2026/0224524 A1Published application
A pharmaceutical composition targeting mutant p53 and her2
OwnerGurdial Singh ARORAinventor
Life of this patent
Estimating the term…
Abstract
The present invention relates to a pharmaceutical composition having anticancer activity. More particularly, the present invention relates to a composition and method for treatment of cancer. Also, the present invention relates to a pharmaceutical composition which targets P53 and HER2.
Claims22
A pharmaceutical composition comprising the following compounds:
- (i)
- (ii)
- (iii)
- (iv)
1 more element
13-18. (canceled)
A compound represented by formula I:
A compound represented by formula III:
(canceled)
The method of claim 17, wherein the cancer is selected from the group consisting of:
- prostate cancer, triple negative breast cancer, invasive cancers, lung cancers, sarcoma, serous carcinoma, pancreatic cancer, and HER2 positive breast cancer.
Dependencies are inferred from the claim text.